Eckhard R PODACK,JOSEPH D ROSENBLATT,KOICHI YAMAZAKI
申请号：
IN7005/DELNP/2010
公开号：
IN2010DN07005A
申请日:
2010.10.01
申请国别(地区):
IN
年份:
2014
代理人:
摘要：
Cell-based immunotherapy (e.g., immunization or vaccination) may be improved by frequent administration to a human subject of allogeneic cancer cells secreting a modified heat shock protein (e.g., gp96), depletion of B cells in the subject, or both. Antigen (e.g., epitope derived from neoantigen or tumor antigen of allogeneic or syngeneic cancer cells) may induce a specific immune response in the subject. For example, the epitope bound in an immunogenic complex with the secreted heat shock protein may be obtained from allogeneic cancer cells coexpressing both secreted gp96 and antigen, or from syngeneic cancer cells of the subject expressing only antigen.
